DSigDB Home
Search Gene
Collections
Browse Gene Sets
Download
Help

Gene Set: D4 : CTD - zafirlukast


Collection D4 : CTD
Chemical Name zafirlukast ( From PubChem : ZAFIRLUKAST )
FDA NPC WHO Indian Australia China Traditional
Herbal
Clinical
Trail
ApprovedNotNotNotNotNotNotNot
Molecular
Weight
Hydrogen Bond
Donor Count
Hydrogen Bond
Acceptor Count
cLogP Lipinski Rule
575.675 g/mol 2 9 7.2406 False(2/4)
Structure
InChI InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)
InChIKey YEEZWCHGZNKEEK-UHFFFAOYSA-N
Links

Gene (43 / 118)


⊖ Less

Source Type Unit Value Gene PMID Assay Other
CTDdecreases(activity)ABCB11
C062735
CTDdecreases(reaction)ABCC1
C062735
CTDdecreases(response to substance)ABCC1
C062735
CTDdecreases(reaction)CXCL8
C062735
CTDincreases(activity)CXCL8
C062735
CTDincreases(expression)CXCL8
C062735
CTDdecreases(reaction)CXCL8
C062735
CTDincreases(activity)CXCL8
C062735
CTDincreases(expression)CXCL8
C062735
CTDdecreases(reaction)CYP1A2
C062735
CTDincreases(metabolic processing)CYP1A2
C062735
CTDdecreases(reaction)CYP2C19
C062735
CTDincreases(metabolic processing)CYP2C19
C062735
CTDdecreases(activity)CYP2C19
C062735
CTDdecreases(activity)CYP2C8
C062735
CTDaffects(metabolic processing)CYP2C9
C062735
CTDdecreases(reaction)CYP2C9
C062735
CTDdecreases(reaction)CYP2C9
C062735
CTDincreases(metabolic processing)CYP2C9
C062735
CTDdecreases(activity)CYP2C9
C062735
CTDincreases(metabolic processing)CYP3A4
C062735
CTDdecreases(reaction)CYP3A4
C062735
CTDincreases(metabolic processing)CYP3A4
C062735
CTDdecreases(activity)CYP3A4
C062735
CTDdecreases(activity)CYP3A4
C062735
CTDaffects(binding)CYSLTR1
C062735
CTDdecreases(activity)CYSLTR1
C062735
CTDdecreases(reaction)CYSLTR1
C062735
CTDaffects(binding)CYSLTR1
C062735
CTDdecreases(activity)CYSLTR1
C062735
CTDaffects(abundance)CYSLTR1
C062735
CTDaffects(binding)CYSLTR1
C062735
CTDdecreases(activity)CYSLTR1
C062735
CTDaffects(binding)CYSLTR1
C062735
CTDdecreases(reaction)CYSLTR1
C062735
CTDincreases(abundance)CYSLTR1
C062735
CTDincreases(reaction)CYSLTR1
C062735
CTDdecreases(reaction)CYSLTR1
C062735
CTDincreases(response to substance)CYSLTR1
C062735
CTDaffects(binding)CYSLTR1
C062735
CTDdecreases(reaction)CYSLTR1
C062735
CTDincreases(activity)CYSLTR1
C062735
CTDaffects(binding)CYSLTR1
C062735
CTDdecreases(reaction)CYSLTR1
C062735
CTDincreases(abundance)CYSLTR1
C062735
CTDincreases(activity)CYSLTR1
C062735
CTDaffects(binding)CYSLTR1
C062735
CTDdecreases(reaction)CYSLTR1
C062735
CTDdecreases(reaction)CYSLTR1
C062735
CTDincreases(activity)CYSLTR1
C062735
CTDincreases(expression)CYSLTR1
C062735
CTDaffects(binding)CYSLTR1
C062735
CTDdecreases(reaction)CYSLTR1
C062735
CTDincreases(activity)CYSLTR1
C062735
CTDaffects(binding)CYSLTR1
C062735
CTDdecreases(reaction)CYSLTR1
C062735
CTDincreases(abundance)CYSLTR1
C062735
CTDincreases(activity)CYSLTR1
C062735
CTDincreases(expression)CYSLTR1
C062735
CTDaffects(binding)CYSLTR2
C062735
CTDdecreases(activity)CYSLTR2
C062735
CTDdecreases(reaction)CYSLTR2
C062735
CTDdecreases(reaction)EDN1
C062735
CTDincreases(expression)EDN1
C062735
CTDdecreases(expression)EDN1
C062735
CTDaffects(cotreatment)IFNG
C062735
CTDdecreases(reaction)IFNG
C062735
CTDincreases(secretion)IFNG
C062735
CTDdecreases(reaction)IL6
C062735
CTDincreases(activity)IL6
C062735
CTDincreases(expression)IL6
C062735
CTDdecreases(expression)RNASE3
C062735
CTDdecreases(reaction)SLC22A2
C062735
CTDincreases(uptake)SLC22A2
C062735
CTDdecreases(reaction)SLC47A1
C062735
CTDincreases(uptake)SLC47A1
C062735
CTDdecreases(reaction)SLC47A2
C062735
CTDincreases(uptake)SLC47A2
C062735
CTDdecreases(reaction)TNF
C062735
CTDincreases(activity)TNF
C062735
CTDincreases(expression)TNF
C062735
PubChem AhR Potency (uM)uM22.384AHR-GI(Protien) :
PubChem Potency-Replicate_1uM26.603AHR-GI(Protien) :
PubChem Potency-Replicate_1uM23.915AR-GI(Protien) :
PubChem PotencyuM50.119BAZ2B-GI(Protien) :
PubChem NoneuMBCL2L1-GI(Protien) :
PubChem IC50uMCACNA1B-GI(Protien) :
PubChem NoneuMCACNA1H-GI(Protien) :
PubChem IC50uMEIF4H-GI(Protien) :
PubChem NoneuMGFER-GI(Protien) :
PubChem PotencyuM21.136GMNN-GI(Protien) :
PubChem PotencyuM7.080KAT2A-GI(Protien) :
PubChem PotencyuM22.387KAT2A-GI(Protien) :
PubChem NoneuMKCNQ1-GI(Protien) :
PubChem PotencyuM28.184MAPK1-GI(Protien) :
PubChem Potency-Replicate_1uM29.847NFE2L2-GI(Protien) :
PubChem Ratio Potency (uM)uM29.847NFE2L2-GI(Protien) :
PubChem EC50uMNOD1-GI(Protien) :
PubChem Potency-Replicate_1uM11.986NR3C1-GI(Protien) :
PubChem NoneuMNRP2-GI(Protien) :
PubChem PotencyuM56.234POLB-GI(Protien) :
PubChem Potency-Replicate_1uM0.169PPARG-GI(Protien) :
PubChem Ratio Potency (uM)uM0.197PPARG-GI(Protien) :
PubChem NoneuMPPP1CA-GI(Protien) :
PubChem IC50uMSAE1-GI(Protien) :
PubChem IC50uMUBA2-GI(Protien) :
PubChem IC50uMUBE2I-GI(Protien) :
PubChem PotencyuM35.481USP1-GI(Protien) :
PubChem PotencyuM50.119VDR-GI(Protien) :
ChEMBLPotencynM50118.700BAZ2B
-Target : CHEMBL1741220
ChEMBLInhibition-CYP1A2
-Target : CHEMBL3356
ChEMBLInhibition-CYP2C19
-Target : CHEMBL3622
ChEMBLInhibition-CYP2C9
-Target : CHEMBL3397
ChEMBLInhibition-CYP2D6
-Target : CHEMBL289
ChEMBLPotencynM22387.200KAT2A
-Target : CHEMBL5501
ChEMBLPotencynM7079.500KAT2A
-Target : CHEMBL5501
ChEMBLPotencynM28183.800MAPK1
-Target : CHEMBL4040
ChEMBLPotencynM56234.100POLB
-Target : CHEMBL2392
Download gene sets gmt, text, Detailed text
Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA

* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).